Presentation is loading. Please wait.

Presentation is loading. Please wait.

Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden.

Similar presentations


Presentation on theme: "Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden."— Presentation transcript:

1 Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013  Prof Louisa Degenhardt, PhD, Fiona Charlson, PhD, Jeff Stanaway, PhD, Sarah Larney, PhD, Lily T Alexander, BA, Prof Matthew Hickman, PhD, Benjamin Cowie, PhD, Prof Wayne D Hall, PhD, Prof John Strang, MD, Prof Harvey Whiteford, PhD, Prof Theo Vos, PhD  The Lancet Infectious Diseases  Volume 16, Issue 12, Pages (December 2016) DOI: /S (16) Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license Terms and Conditions

2 Figure 1 Distribution of absolute DALYs attributable to injecting drug use, 2013 DALYs attributable to injecting drug are for HIV (A), hepatitis C virus (B), hepatitis B virus (C), and HIV, hepatitis C virus, and hepatitis B virus combined (D). DALY=disability-adjusted life-year. The Lancet Infectious Diseases  , DOI: ( /S (16) ) Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license Terms and Conditions

3 Figure 2 Proportion of total burden of HIV attributable to injecting drug use by country, 2013 ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste. FSM=Federated States of Micronesia. The Lancet Infectious Diseases  , DOI: ( /S (16) ) Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license Terms and Conditions

4 Figure 3 Proportion of total burden of hepatitis C virus attributable to injecting drug use by country, 2013 ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste. FSM=Federated States of Micronesia. The Lancet Infectious Diseases  , DOI: ( /S (16) ) Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license Terms and Conditions

5 Figure 4 Proportion of total burden of hepatitis B virus attributable to injecting drug use by country, 2013 ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste. FSM=Federated States of Micronesia. The Lancet Infectious Diseases  , DOI: ( /S (16) ) Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license Terms and Conditions


Download ppt "Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden."

Similar presentations


Ads by Google